Breaking News

WCG Granted Extended ISO 9001 Certification

Reinforces commitment to excellence of quality management across ethical review.

WCG, a company that provides clinical research services, reported the extension of its ISO 9001 certification to its Institutional Biosafety Committee (IBC) services by BSI. WCG has now achieved ISO 9001 certification for both its Institutional Review Board (IRB) and IBC services.

ISO 9000 standards are based on a series of quality management principles. They require company leaders to establish clear goals and objectives for their quality management system and endeavor to get all their employees involved. Participating companies adopt a strong customer focus with employees aiming not just to meet customer expectations but to exceed them. They also take both a process- and systems-based management approach and strive for continual improvement in their company’s overall performance, using internal audits to track progress.

“In 2010, WCG’s IRB became the only IRB in the world to have met ISO quality management standards and to have received ISO 9001 certification,” said WCG CEO Sam Srivastava. “Today, we are proud to raise the bar yet again as we have set a new high standard for quality management in ethical review within our IBC.”

“WCG has been leading ethical review for decades,” said David Forster, chief compliance officer, WCG. “We were the first to pioneer the concept of independent ethical review, and we continually seek ways to increase efficiencies within the clinical research process while maintaining the highest standards of human subject protection. Achieving ISO certification within our IBC is a powerful indicator of our commitment to continuous improvement in all aspects of our operations.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters